Svenskhampahttps://svenskhampa.se/en/Reporting and investigation on the hemp industryen-GBEveryone is moving south — but the Nordic climate yields more CBDAhttps://svenskhampa.se/en/nordic-climate-more-cbda/https://svenskhampa.se/en/nordic-climate-more-cbda/Wed, 05 Aug 2026 14:00:00 +0200Europe's CBD industry has spent a decade moving south to fetch sunlight. But sunlight and heat are not the same thing: a peer-reviewed study shows cannabinoid yield more than halves between 25 and 31 degrees. A normal July on the Po Plain sits at the higher figure. Visby sits inside the optimum.He sold brickshttps://svenskhampa.se/en/he-sold-bricks/https://svenskhampa.se/en/he-sold-bricks/Fri, 31 Jul 2026 22:15:00 +0200In 2022 a US state regulator found that King Kong Organics and Edouard Joseph had sold unqualified securities and made untrue statements to investors. Three and a half years later he appears on CNBC Africa.What chronic stress does to the endocannabinoid system — and what the research still does not knowhttps://svenskhampa.se/en/chronic-stress-endocannabinoid-system/https://svenskhampa.se/en/chronic-stress-endocannabinoid-system/Mon, 27 Jul 2026 14:58:18 +0200Prolonged stress depletes the body of its own anandamide. The mechanism is mapped down to the level of a single enzyme and measured in humans with PET imaging. But nobody has taken the step to whetherCBD and addiction: what the research showshttps://svenskhampa.se/en/cbd-and-addiction-what-research-shows/https://svenskhampa.se/en/cbd-and-addiction-what-research-shows/Sun, 31 May 2026 05:19:24 +0200UCL 2013: 24 smokers using a CBD inhaler cut consumption by 40%. A Mount Sinai study on opioid dependence: reduced craving and anxiety. More consistent data than in other areas.New CBD study 2026: 90 million users in the UShttps://svenskhampa.se/en/new-cbd-study-2026-90-million-users/https://svenskhampa.se/en/new-cbd-study-2026-90-million-users/Sun, 31 May 2026 05:19:18 +0200Frontiers in Public Health 2026: 35.2% of US adults have tried CBD (~90 million). 32% use CBD alongside medication. 1,523 adults surveyed.Advocates push for wider access to medical cannabis in women’s health conditionshttps://svenskhampa.se/en/womens-cannabis-project-eu-framework/https://svenskhampa.se/en/womens-cannabis-project-eu-framework/Sun, 31 May 2026 04:52:04 +0200The Women’s Cannabis Project has developed a European policy framework for medical cannabis in women’s health conditions. The initiative builds on US state decisions and concerns prescription medicineACMD’s 2016 phytocannabinoid report — the UK policy that shaped CBD, and the questions it never answeredhttps://svenskhampa.se/en/acmd-phytocannabinoid-working-group-2016-en/https://svenskhampa.se/en/acmd-phytocannabinoid-working-group-2016-en/Thu, 28 May 2026 13:39:22 +0200In December 2016 an ACMD working group filed a report that locked in 12 phytocannabinoids as controlled substances under UK law. The chair moved to GW Pharmaceuticals the following year. The report coEFSA, Novel Food and CBD — where the decision stands in May 2026https://svenskhampa.se/en/efsa-novel-food-cbd-2026-en/https://svenskhampa.se/en/efsa-novel-food-cbd-2026-en/Thu, 28 May 2026 13:39:19 +0200EFSA set a provisional safe intake level for CBD of ~2 mg/day in February 2026. Behind the number lies a deeper structural problem: hemp has been consumed in Europe for thousands of years, but a 2019